CANEPARO, Valeria
CANEPARO, Valeria
SCIENZE DELLA SANITA' PUBBLICA E PEDIATRICHE
Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cells
2022-01-01 Raviola S, Griffante G, Iannucci A, Caneparo V, Lacarbonara D, Chandel S, Lo Cigno I, Favero F, Corà D, Cantaluppi V, Landolfo S, Gariglio M, De Andrea M.
IFI16 and Anti-IFI16 as Novel Biomarkers for Sjoegren’s Syndrome: Preliminary Data
2019-01-01 Marino, Sonia; Gualtierotti, Roberta; Caneparo, Valeria; De Andrea, Marco; Gariglio, Marisa; Meroni, Pier Luigi; Bossi, Eleonora; Spadari, Francesco
IL-6-mediated paracrine senescence drives the intercellular communication within the HCMV microenvironment in renal epithelial cells
2023-01-01 Raviola S, Iannucci A, Caneparo V, Lacarbonara D, Castiglioni F, Lo Cigno I, Favero F, Corà D, Cantaluppi V, Landolfo S, Gariglio M, De Andrea M.
P178 Validation of the clinical utility of IFI16-based markers in IBD
2017-01-01 V. Caneparo, L. Pastorelli, E. Vanni, D. Roggenbuck, R. Boldorini, M. Astegiano, M. Vecchi, S. Landolfo, M. Gariglio, M. De Andrea
P600 Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD
2018-01-01 Caneparo, V; Verstockt, B; Vermeire, S; Landolfo, S; Gariglio, M; De Andrea, M
The PYRIN domain of IFI16 drives LPS-induced and sterile toll-like receptor 4-mediated inflammation
2023-01-01 Lacarbonara D, Iannucci A, Caneparo V, Raviola S, Martinello G, Miggiano R, Gariglio M, De Andrea M.
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD)
2017-01-01 Astegiano, M.; Vanni, E.; Finocchiaro, F.; Vernero, M.; Ribaldone, D.; Reggiani, S.; Caviglia, G.; De Andrea, M.; Caneparo, V.; Landolfo, S.; Gariglio, M.; Smedile, A.; Pellicano, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cells | 2022 | Raviola S, Griffante G, Iannucci A, Caneparo V, Lacarbonara D, Chandel S, Lo Cigno I, Favero F, Corà D, Cantaluppi V, Landolfo S, Gariglio M, De Andrea M. | |
| IFI16 and Anti-IFI16 as Novel Biomarkers for Sjoegren’s Syndrome: Preliminary Data | 2019 | Marino, Sonia; Gualtierotti, Roberta; Caneparo, Valeria; De Andrea, Marco; Gariglio, Marisa; Meroni, Pier Luigi; Bossi, Eleonora; Spadari, Francesco | |
| IL-6-mediated paracrine senescence drives the intercellular communication within the HCMV microenvironment in renal epithelial cells | 2023 | Raviola S, Iannucci A, Caneparo V, Lacarbonara D, Castiglioni F, Lo Cigno I, Favero F, Corà D, Cantaluppi V, Landolfo S, Gariglio M, De Andrea M. | |
| P178 Validation of the clinical utility of IFI16-based markers in IBD | 2017 | V. Caneparo, L. Pastorelli, E. Vanni, D. Roggenbuck, R. Boldorini, M. Astegiano, M. Vecchi, S. Landolfo, M. Gariglio, M. De Andrea | |
| P600 Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD | 2018 | Caneparo, V; Verstockt, B; Vermeire, S; Landolfo, S; Gariglio, M; De Andrea, M | |
| The PYRIN domain of IFI16 drives LPS-induced and sterile toll-like receptor 4-mediated inflammation | 2023 | Lacarbonara D, Iannucci A, Caneparo V, Raviola S, Martinello G, Miggiano R, Gariglio M, De Andrea M. | |
| THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) | 2017 | Astegiano, M.; Vanni, E.; Finocchiaro, F.; Vernero, M.; Ribaldone, D.; Reggiani, S.; Caviglia, G.; De Andrea, M.; Caneparo, V.; Landolfo, S.; Gariglio, M.; Smedile, A.; Pellicano, R. |